adverse outcomes, defined as death, sustained ventricular tachycardia (vt), and increase in new york heart association functional class to grade ii or iv, occurred in 21% of patients.
确定死亡、持续性室性心动过速、纽约心功能分级增加到ii或iv级等负性结果发生率为21%。
conclusion: large-dose intravenous amiodarone therapy for sustained ventricular tachycardia (svt) in patients with acute myocardial infarction (ami) is highly effective and quite safe.